Home » Topics » BioWorld Science

BioWorld Science
RSS

Ciba-Geigy claims renin inhibitors

March 15, 1996

Kyowa Hakko reports endothelin antagonists

March 15, 1996

Uriach antihypertensive drug update

March 15, 1996

Lercanidipine approval imminent

March 15, 1996

Lexipafant asthma trial update

March 15, 1996

Terumo TxA2/LTD4 antagonists for asthma

March 15, 1996

Fujisawa claims PDE IV/TNF inhibitors

March 15, 1996

Uriach discontinues antiasthma drug

March 15, 1996

Nasacort effective in hay fever sufferers

March 15, 1996

Uriach PAF antagonist/antihistamine for allergic rhinitis

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...